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Information on the levels of angiotensin II (Ang II) and its
receptors in the various renal tissue compartments is still
incomplete. A model is presented describing the kinetics of
Ang II production, distribution, and disposal in the renal
cortex. Basic features are: (1) the model is designed to derive,
from Ang II measurements in blood and in whole tissue,
estimates of the local densities of the Ang II type 1 (AT1) and
type 2 (AT2) receptors, and to calculate the concentrations of
endocrine and paracrine Ang II they actually ‘see’; (2)
glomerular and peritubular tissue are conceived as separate
regions (glomerular region (Glom), peritubular region (Pt));
(3) in Glom and in Pt, Ang II is homogeneously distributed in
capillary blood and in interstitial fluid; (4) the model allows
for local Ang II concentration gradients between interstitium
and blood; (5) Ang II from the circulation diffuses into the
interstitium of Glom after convective transcapillary transport;
(6) Ang II produced in tubules or Pt enters the
microcirculation through diffusive overflow from interstitium;
(7) the presence of cell-surface-bound Ang II depends on the
reaction with AT1 and AT2 receptors, and the presence of
intracellular Ang II depends on the internalization of Ang II –
AT1 receptor complex; and (8) the model provides for
glomerular filtration, vasopeptidase-mediated degradation,
and intracellular degradation as mechanisms of elimination.
This model can serve as a framework for detailed quantitative
studies of the renin–angiotensin system in the kidney.
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The renin–angiotensin system is part of the complex
regulation of blood pressure, renal function, and body
sodium and water homeostasis. The most important
biologically active end product of this system, angiotensin
(Ang) II, is thought to act both as a circulating hormone
and as a paracrine factor. The physiological significance of
paracrine Ang II, as opposed to circulating Ang II, is still not
well understood.
In humans, under normal conditions, the concentration of
Ang II in blood plasma is approximately 10 pM at a daily
sodium intake typical of Western industrialized coun-
tries,1,2 which is close to the threshold level required to elicit
a physiological response. After dietary sodium restriction,
either alone or in combination with the use of a diuretic, Ang
II can increase 10-fold. Under pathological conditions, it can
increase 100-fold or even more. In anesthetized animals, the
concentration of circulating Ang II is often higher than the
levels normally encountered in humans.
In humans as well as in anesthetized animals, the Ang II
concentration in some tissues (per gram of tissue), including
the kidney, is higher than in plasma (per ml).3–7 Some
authors measured Ang II levels in the nanomolar range in
cardiac and renal tissue fluid,8–11 which would fit with the
value of the equilibrium dissociation constant of the Ang
II–Ang II type 1 (AT1) receptor and Ang II–Ang II type 2
(AT2) receptor reactions (Kd¼ 1–2 nM). According to others,
however, the interstitial fluid levels are much lower.7,12,13
Rather, it now appears that Ang II in the tissue is cell-
associated owing to its binding to cell surface AT1 and
possibly also AT2 receptors. Studies in rats demonstrated
AT1-receptor-dependent intrarenal accumulation of systemi-
cally infused Ang II14 and provided evidence of AT1 receptor-
mediated renal uptake of endogenous Ang II after dietary salt
restriction.15 The binding to cell surface AT1 receptors is
known to be followed by rapid internalization of Ang II–AT1
receptor complex.16
Experiments in pigs showed that intact 125I-Ang II from
the circulation was accumulated in cardiac, renal, and adrenal
tissue, and that the uptake of 125I-Ang II was greatly reduced
after the animals had been treated with an AT1 receptor
antagonist.17 The steady-state tissue/blood 125I-Ang II
concentration ratio was adrenal4kidney4heart, which is
in accordance with the order of AT1 receptor density in these
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tissues as well as with the order of endogenous Ang II
concentration.3,4,7,17
Published results of Ang II measurements in blood
plasma, in tissue extracellular fluid, and in whole tissue raise
a number of important questions. How can circulating,
endocrine, Ang II act at such a low concentration? What are
the local AT1 and AT2 receptor concentrations in tissue? What
are the Ang II concentrations the AT1 and AT2 receptors in
tissue actually ‘see’? How much of it is of local, paracrine,
origin?
This paper focuses on the kidney and, to address the above
questions, a quantitative model is presented describing the
kinetics of the intrarenal production, distribution, and
elimination of Ang II. The model is designed as a tool to
calculate the intrarenal levels of extracellular and cell-bound
Ang II as well as to estimate the local concentrations of cell
surface AT1 and AT2 receptors, from Ang II measurements in
blood plasma and in whole tissue. The aim of the model also
is to provide for separate estimates of endocrine and
paracrine Ang II levels.
GENERAL CHARACTERISTICS OF THE MODEL
Tables 1–3 provide a list of abbreviations, symbols, and
definitions, as well as the values of the various physical
parameters and kinetic constants. An important feature is the
distinction between endocrine Ang II (IIa) delivered to the
tissue via the renal artery and paracrine Ang II (IIi) that is
produced intrarenally. Ang IIa and Ang IIi in renal venous
plasma and in tissue can be measured separately in samples
obtained from animals receiving systemic infusions of
radiolabeled Ang I or II.7,17 Similarly, separate measurements
of Ang Ia and Ang Ii can be obtained during a systemic
infusion of radiolabeled Ang I.
The model considers three cortical tissue regions, the
glomerular region (Glom), the tubular region (Tb), and the
peritubular region (Pt). The glomerular capillary plasma and
interstitial fluid compartments (PcGlom, IsfGlom) are con-
nected in series with the corresponding peritubular compart-
ments (PcPt, IsfPt). The two plasma compartments are
connected via the glomerular efferent arterioles, and the two
interstitial fluid compartments are connected via the inter-
stitium at the level of the glomerular vascular pole (Figure 1).
Ang I and II from blood reach the glomerular ultrafiltrate
via the glomerular capillaries by convection, and it is assumed
that some Ang II, after its passage through the capillary
endothelium, reaches glomerular (mesangial) cell surface
receptors by diffusion into the interstitium (Figure 2).
Binding of Ang II to cell surface AT1 receptors, but not AT2
receptors, is followed by internalization of the Ang II–AT1
receptor complex and degradation of Ang II by intracellular
(lysosomal) enzymes.16,18 Free Ang I and II in glomerular
interstitial fluid are thought to be homogeneously distrib-
uted, under steady-state conditions.
It is further assumed that the release of intrarenally
produced Ang I and II into the renal interstitial fluid is
confined to the peritubular tissue region. The exact sites of
Ang I and II production in the kidney are not known, but an
extensive series of micropuncture experiments in rats by
Navar and co-workers have shown that the levels of Ang I and
II in proximal tubular fluid are 10 to 100 times higher than in
blood plasma, and that angiotensinogen is also present in
high concentrations in proximal tubular fluid.19,20 These
experiments also provided evidence to support that Ang I
and II as well as angiotensinogen are secreted by the proximal
tubular cells into the tubular fluid.20,21 The intrarenal
localization of angiotensin-converting enzyme (ACE) at the
brush border of proximal tubular cells is in accordance with
this hypothesis.22
In our model, a net transport of Ang I and II is therefore
assumed to exist from tubular fluid into the peritubular
interstitial fluid compartment and from there into the
peritubular capillaries (Figure 3). The capillary–interstitial
exchange of Ang I and II in the Pt is thought to depend on
diffusion, and here our analysis, while allowing for the
existence of an endothelial diffusion barrier, follows the so-
called tissue homogeneity model.23 According to this model,
capillary entrances and exits are randomly distributed
throughout the tissue, and the interstitial fluid compartment
as well as the plasma compartment in capillaries and veins are
conceived as being well-mixed.
The model implies that the presence of cell-associated Ang
II in the renal cortex depends on the binding of extracellular
Ang II to cell surface AT1 and AT2 receptors. Experiments
using systemic infusions of 125I-Ang I or II in pigs showed
more than 90% reduction of the tissue/blood 125I-Ang II
concentration ratio in the renal cortex after AT1 receptor
antagonist treatment.7 This indicates that indeed the bulk of
arterially delivered Ang II is cell-associated as a consequence
of its reaction with AT1 receptors. Cell fractionation studies
of porcine renal cortical tissue, with the use of differential
centrifugation, indicated that not only most of systemically
infused 125I-Ang II but also most endogenous Ang II is
bound to cell organelles, whereas exogenous and endogenous
Ang II were similarly distributed over the various subcellular
fractions.24 Similar data were obtained by others.25,26
ARTERIALLY DELIVERED ANG I AND II
Concentrations in interstitial fluid
The concept set out above leads to the following steady-state
equations:
CIaIsfGlom ¼ CIPa ð1Þ
CIIaIsfGlom ¼ CIIPa  RMEIIaGlom=ðQ FFÞ ð2Þ
CIaIsfPt ¼ CIaPv ð3Þ
CIIaIsfPt ¼ CIIaPv  RMEIIaPt=ClDiffPt ð4Þ
1544 Kidney International (2006) 69, 1543–1552
o r i g i n a l a r t i c l e MADH Schalekamp and AHJ Danser: Angiotensin II production and distribution
Vasopeptidase-mediated degradation
Concerning the elimination of extracellular Ang IIa, the
model provides for the following mechanisms: glomerular
filtration, vasopeptidase-mediated degradation, and AT1
receptor-mediated endocytosis. It is known that only a small
fraction of systemically infused Ang I is converted into Ang II
in the kidney,27 and studies in pigs, with the use of infusions
of either 125I-Ang I or 125I-Ang II, justify the conclusion that,
Table 1 | Abbreviations, symbols, and definitions
Symbol or abbreviation Definition
Renal compartments
Pa Renal arterial plasma
Pv Renal venous plasma
Pc Capillary plasma
Isf Interstitial fluid
Tb Tubular region of renal cortex
T Renal cortex
Glom Glomerular region
Pt Peritubular region of renal cortex
Cs Cell surface
Ce Cell interior
Angiotensins from different sources
I Ang I
II Ang II
IIa Arterially delivered Ang II
IIi Intrarenally produced Ang II
Angiotensin in different compartments
IIPa, IIPv Plasma Ang II in renal artery, vein
IIPcGlom, IIPcPt Plasma Ang II in glomerular, peritubular capillaries
IIIsfGlom, IIIsfPt Ang II in glomerular, peritubular interstitial fluid
IIC1 AT1 receptor-dependent cell-associated (surface-bound and intracellular) Ang II
IIC1Glom, IIC1Pt AT1 receptor-dependent cell-associated Ang II in glomerular, peritubular region
IICs1Glom, IICs1Pt Ang II bound to cell surface AT1 receptors in glomerular, peritubular region
IICs2Pt Ang II bound to cell surface AT2 receptors in peritubular region
IIT Ang II in renal cortex
IITb Ang II in tubular fluid
Receptors
AT1RCsGlom, AT1RCsPt Cell surface AT1 receptors in glomerular, peritubular region
AT2RCsPt Cell surface AT2 receptors in peritubular region
Concentrations
CI, CII Concentration of Ang I, Ang II
CAT1R, CAT2R Concentration of AT1-, AT2 receptors
(CI)1,2, (CII)1,2 Concentration of Ang I, Ang II in the absence of AT1- and AT2 receptor blockade
(CI)1, (CII)1 Concentration of Ang I, Ang II in the presence of AT2 receptor blockade
(CI)2, (CII)2 Concentration of Ang I, Ang II in the presence of AT1 receptor blockade
Elimination mechanisms
VMD Vasopeptidase-mediated degradation
RME AT1 receptor-mediated endocytosis
ClRME Clearance by RME
Physical parameters
VPcGlom, VPcPt Volume of glomerular, peritubular capillary blood plasma
VIsfGlom, VIsfPt Volume of glomerular, peritubular interstitial fluid
Q Renal cortical plasma flow
FF Filtration fraction
ClDiffPt Diffusive clearance across peritubular capillaries
Kinetic constants
Kd Equilibrium dissociation constant of the Ang II–AT1 and Ang II–AT2 receptor reactions
kass Rate constant for Ang II–AT1 receptor complex formation
kdiss Rate constant for Ang II–AT1 receptor complex dissociation
kint Rate constant for AT1 receptor-mediated Ang II endocytosis
klys Rate constant for (lysosomal) intracellular Ang II degradation
ktel Rate constant for the elimination of cell-associated (surface-bound and intracellular) Ang II
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for the purpose of the present analysis, Ang I–II conversion
by renal vasopeptidase can be ignored and that the
degradation rate constants are similar for Ang I and
II.17,28,29 The rate of vasopeptidase-mediated degradation of
Ang Ia into peptides other than Ang II, at steady state, is
therefore given by
VMDIa ¼ CIPa Qð1  FF  CIaPv=CIPaÞ ð5Þ
Similarly,
VMDIIa ¼ CIIPa Qð1  FF  CIaPv=CIPaÞ ð6Þ
Binding to cell surface AT1 and AT2 receptors and AT1
receptor-mediated endocytosis
As mentioned above, experiments using systemic infusions of
125I-Ang I or II in pigs indicate that the bulk of Ang IIa
present in tissue is cell-associated as a consequence of its
reaction with AT1 receptors. Ang IIa, after its binding to cell
surface AT1 receptors, reaches the cell interior through AT1
receptor-mediated endocytosis. For the purpose of the
present analysis, it can be stated that
CIIaT ¼ CIIaC1 ð7Þ
CIIaC1 ¼ CIIaCs1 VIsf þ CIIaCe1 ð8Þ
Steady-state equations describing the binding of Ang IIa to
cell surface AT1 receptors, its internalization and its
intracellular degradation are
CIIaIsf CAT1RCs kass ¼ CIIaCs1ðkdiss þ kintÞ ð9Þ
RMEIIa ¼ CIIaCs1 VIsf kint ð10Þ
Table 2 | Units of parameters
Concentrations
CIIPa CIIPv, CIIPc mol/ml of blood plasma
CIIIsf, CIICs mol/ml of interstitial fluid
CIITb, CIIT, CIIC1 mol/g of renal cortex
CAT1RCs, CAT2RCs mol/ml of interstitial fluid
Physical parameters and kinetic constants
VPc, VIsf ml/g of renal cortex
Q, ClDiffPt, ClRME ml/min per g of renal cortex
Kd mol/ml
kass /(mol/ml) per min
kdiss, kint, klys, ktel min
1
RMEII mol/min per g of renal cortex
VMDI, VMDII mol/min per g of renal cortex
Table 3 | Values of physical parameters and kinetic constants
Parameter Value Reference
VIsfGlom (5) 103/ml per g 33
VIsfPt 0.1 ml/g
33
Q 2 ml/min per g 34
FF 0.20 35
ClDiffPt 0.3 ml/min per g See text
Kd (for AT1 – and AT2 receptors) (1.5) 1012 mol/ml 36,37
kass (for AT1 receptors) (2.4) 1010/(mol/ml) per min 36
kdiss (for AT1 receptors) (3.6) 102 min1 Derived from Kd and kass
ktel (2.7) 102 min1 17
kint (35) 102 min1 See text
klys (2.9) 102 min1 Derived from ktel and kint (see Eq. (13))
Pc Glom
Isf Glom
Tb
Pc Pt
Isf Pt
Tubules
Capillaries
Interstitial
fluid
Glomerular
tissue region
Peritubular
tissue region
Pa Pv
Renal
vein
Renal
artery
Afferent
arteriole
Efferent
arteriole
Figure 1 | Schematic representation of the extracellular fluid
compartments in the glomerular and peritubular tissue regions
of the renal cortex. For an explanation of abbreviations, see Table 1.
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Figure 2 | Schematic representation of extracellular transport and
intracellular trafficking of endocrine angiotensin II in the
glomerular tissue region.
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CIIaCs1 VIsf kint ¼ CIIaCe1 klys ð11Þ
The experiments in pigs mentioned above showed a quasi-
mono-exponential decrease of 125I-Ang II from the renal
cortex after the infusion of tracer had been stopped. It can
therefore be stated that
RMEIIa ¼ CIIaT ktel ð12Þ
From Eqs. (7), (8), and (10)–(12), it follows that
ktel ¼
kintklys
ðkint þ klysÞ ð13Þ
In accordance with Eqs. (7) and (12), it follows from Eqs. (2)
and (4) that
CIIaIsfGlom ¼ CIIPa  CIIaC1Glom ktel=ðQ FFÞ ð14Þ
CIIaIsfPt ¼ CIIaPv  CIIaC1Pt ktel=CIDiffPt ð15Þ
The implicit assumption underlying Eqs. (14) and (15) is that
ktel has the same value in the glomerular and peritubular
tissue regions.
In Eqs. (5), (6), and (12), the rates of vasopeptidase-
mediated Ang Ia and IIa degradation and the rate of AT1
receptor-mediated Ang IIa endocytosis are expressed as a
function of the plasma concentration of Ang I in the renal
artery, the concentrations of Ang Ia and Ang IIa in the renal
vein, and the total tissue concentration of Ang IIa in the renal
cortex. These independent variables can be measured.
INTRARENALLY PRODUCED ANG I AND II
Concentrations in interstitial fluid, spillover into the micro-
circulation, and vasopeptidase-mediated degradation
The contribution of Ang I that is produced in the renal
microcirculation by the action of circulating renin to the total
concentration of Ang Ii in the renal vein is very small.29 It can
be ignored for the purpose of the present analysis and, as set
out above, the same can be said for the Ang I–II conversion
by renal vasopeptidase. It can therefore be stated that the
spillover of Ang Ii and IIi into the microcirculation is given
by the sum of the vasopeptidase-mediated degradation rate
and the outflow via the renal vein. In Eqs. (5) and (6), the
rates of vasopeptidase-mediated Ang Ia and IIa degradation
are expressed as a fraction of the rate of delivery via the renal
artery, the fraction being equal to (1FFCIaPv/CIPa). The
rates of vasopeptidase-mediated Ang Ii and IIi degradation
can be expressed in a similar way, as a fraction of the spillover
rate, so that
Spillover Ii ¼ CIiPv Q=ðFF þ CIaPv=CIPaÞ ð16Þ
Spillover IIi ¼ CIIiPv Q=ðFF þ CIaPv=CIPaÞ ð17Þ
VMDIi ¼ CIiPv Q½1=ðFF þ CIaPv=CIPaÞ  1 ð18Þ
VMDIIi ¼ CIIiPv Q½1=ðFF þ CIaPv=CIPaÞ  1 ð19Þ
Spillover of Ang Ii and IIi into the microcirculation is related
to the concentration gradient across the peritubular capil-
laries, as follows:
Spillover Ii ¼ ðCIiIsfPt  CIiPvÞClDiffPt ð20Þ
Spillover IIi ¼ ðCIIiIsfPt  CIIiPvÞClDiffPt ð21Þ
From Eqs. (16), (17), (20), and (21), it follows that
CIiIsfPt ¼ aCIiPv ð22Þ
CIIiIsfPt ¼ aCIIiPv ð23Þ
where
a ¼ 1 þ Q=½ðFF þ CIaPv=CIPaÞClDiffPt ð24Þ
In Eqs. (16)–(19) and (22)–(24), the spillover of Ang Ii and IIi
into the microcirculation, the degradation of Ang Ii and IIi
by vasopeptidases, and the concentrations of Ang Ii and IIi in
interstitial fluid are expressed as a function of the plasma
concentration of Ang I in the renal artery and the
concentrations of Ang Ia, Ii, and IIi in the renal vein. These
independent variables can be measured.
Distribution over the interstitial and tubular fluid compart-
ments
In our model, it is assumed that Ang I in tissue is confined to
the extracellular fluid compartments so that, in the absence
of Ang I production in the glomerular tissue region, under
steady-state conditions
CIiT ¼ CIiPcPt VPcPt þ CIiIsfPt VIsfPt þ CIiTb ð25Þ
We further define the distribution of Ang Ii by
b ¼ CIiTb=ðCIiIsfPt VIsfPtÞ ð26Þ
Diffusion
Overflow into renal vein
Degradation by vasopeptidases
Ang II degradationEndocytosis
AT1
receptor
Receptor
Recycling
Tubular fluid
Tubular wall
Peritubular
interstitial
fluid
Peritubular
capillary wall
Blood plasma
Tubular cell
VSM cell
Angiotensin II Angiotensin I
Diffusion
ACE
Figure 3 | Schematic representation of extracellular transport and
intracellular trafficking of paracrine angiotensin II in the tubular
and peritubular cortical tissue regions.
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With respect to the distribution of Ang IIi in the presence of
AT1 receptor blockade and in the absence of AT1 and AT2
receptor blockade, the notations b2 and b1,2, respectively, are
used. This distinction is necessary, because the clearance of
Ang IIi from peritubular interstitial fluid, in contrast with the
clearance of Ang Ii, does not only depend on diffusion into
blood but also on AT1 receptor-mediated endocytosis.
Anatomically, the tubular tissue region comprises the
tubular fluid compartment as well as its cell lining. It seems,
however, reasonable to assume that the basolateral tubular
cell receptors are exposed to a concentration of Ang II not
too different from the concentration in peritubular inter-
stitial fluid, whereas apical receptors are indeed exposed to an
Ang II concentration equal to that in the tubular fluid
compartment. The apical receptors are bathed in a relatively
large volume of tubular fluid and it is therefore assumed that
only a small fraction of the total amount of Ang IIi in tubular
fluid is bound to these receptors and that this fraction can be
ignored. The term CIiPcPt VPcPt in Eq. (25) is very small as
compared with CIiT
7 and, for the practical purpose of our
analysis, it is also ignored.
Thus, in accordance with Eq. (22), it follows that
b2 ¼ b ¼ ½ðCIiT=CIiPvÞ=ðaVIsfPtÞ  1 ð27Þ
b1;2 ¼ b½ðClIIiPtRMEÞ1;2 þ ClDiffPt=ClDiffPt ð28Þ
In Eq. (27), the factor b is expressed as a function of the
plasma concentration of Ang Ii in the renal vein, the total
tissue concentration of Ang Ii in the renal cortex, the plasma
concentration of Ang I in the renal artery, and the
concentration of arterially delivered Ang I in the renal vein.
These independent variables can be measured.
Binding to cell surface AT1 and AT2 receptors and AT1
receptor-mediated endocytosis
Part of Ang IIi in the renal cortex is localized in the tissue
extracellular fluid compartments, and part of it is cell-bound
as a consequence of the binding to cell surface AT1 and AT2
receptors and AT1 receptor-mediated endocytosis. It is further
assumed that the bulk of cell-associated Ang IIi is localized in
the peritubular tissue region, possibly including the basolateral
part of tubular cells, so that under steady-state conditions
CIIiT ¼CIIiPcPt VPcPt þ CIIiIsfPt VIsfPt þ CIIiTb
þ CIIiC1Pt þ CIIiCs2Pt VIsfPt
ð29Þ
The tissue concentration of Ang IIi that is confined to the
fluid-phase extracellular milieu is represented by the first
three terms of the right part of this equation, and the tissue
concentration of cell-associated Ang IIi is represented by the
last two terms. The term CIIiPcPtVPcPt is very small as
compared with CIIiT,
7 and can be ignored, so that Eq. (29)
can be simplified into
CIIiT ¼ CIIiIsfPt VIsfPt þ CIIiTb þ CIIiC1Pt
þ CIIiCs2Pt VIsfPt ð30Þ
In order to distinguish the experimental data obtained under
AT1 receptor blockade from data obtained in the absence of
AT1 and AT2 receptor blockade, the notations (CIIi)2 and
(CIIi)1,2, respectively, will be used. Thus,
ðCIIiTÞ1;2 ¼ðCIIiIsfPtÞ1;2VIsfPt þ ðCIIiTbÞ1;2
þ ðCIIiC1PtÞ1;2 þ ðCIIiCs2PtÞ1;2VIsfPt
ð31Þ
ðCIIiTÞ2 ¼ðCIIiIsfPtÞ2VIsfPt þ ðCIIiTbÞ2
þ ðCIIiCs2PtÞ2 VIsfPt
ð32Þ
In accordance with Eq. (26), it follows from Eqs. (31) and
(32) that
ðCIIiC1PtÞ1;2 ¼ðCIIiTÞ1;2  ðb1;2 þ 1ÞðCIIiIsfPtÞ1;2VIsfPt
 ðCIIiCs2PtÞ1;2VIsfPt
ð33Þ
ðCIIiCs2PtÞ2 ¼ ðCIIiTÞ2=VIsfPt  ðb2 þ 1ÞðCIIiIsfPtÞ2 ð34Þ
Assuming the concentration of cell surface AT2 receptors
(free plus occupied) not being altered by AT1 receptor
blockade, it can be stated that
ðCIIiCs2PtÞ1;2=ðCIIiIsfPtÞ1;2 ¼ ðCIIiCs2PtÞ2=ðCIIiIsfPtÞ2 ð35Þ
In accordance with Eq. (23), it follows from Eqs. (33) to (35) that
ðCIIiC1PtÞ1;2 ¼ gðCIIiPvÞ1;2  aðb1;2  b2ÞðCIIiPvÞ1;2VIsfPt
ð36Þ
where
g ¼ ðCIIiTÞ1;2=ðCIIiPvÞ1;2  ðCIIiTÞ2=ðCIIiPvÞ2 ð37Þ
In accordance with Eq. (12), it can be stated that
ðRMEIIiPtÞ1;2 ¼ ðCIIiC1PtÞ1;2ktel ð38Þ
so that
ðClIIiPtRMEÞ1;2 ¼ ðCIIiC1PtÞ1;2ktel=ðCIIiIsfPtÞ1;2 ð39Þ
In accordance with Eq. (23), it follows from Eqs. (27), (28),
and (36)–(39) that
b1;2  b2 ¼ ðg=aÞbktel=ðClDiffPt þ bVIsfPtktelÞ ð40Þ
where a is given by Eq. (24), b by Eq. (27), and g by Eq. (37).
From Eqs. (27), (28), and (38)–(40), it follows that
ðCIIiC1PtÞ1;2 ¼
gðCIIiPvÞ1;2 ClDiffPt
ðClDiffPt þ bVIsfPtktelÞ ð41Þ
ðRMEIIiPtÞ1;2 ¼
gðCIIiPvÞ1;2 ClDiffPtktel
ðClDiffPt þ bVIsfPtktelÞ ð42Þ
In accordance with Eq. (23), it follows from Eqs. (27) and
(34) that
ðCIIiCs2PtÞ2 ¼ ðCIIiTÞ2=VIsfPt  a 	 ðbþ 1ÞðCIIiPvÞ2 ð43Þ
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In Eqs. (41) and (42), the AT1 receptor-dependent concen-
tration of cell-associated Ang IIi and the rate of AT1 receptor-
mediated endocytosis are expressed as a function of the
plasma concentrations of Ang Ii and Ang IIi in the renal vein
and the total tissue concentrations of Ang Ii and Ang IIi in
the renal cortex. These independent variables can be
measured. In Eq. (43), the AT2 receptor-dependent concen-
tration of cell-associated Ang IIi is expressed as a function of
the same variables in combination with the factor a, as given
by Eq. (24). This factor depends on the plasma concentration
of Ang I in the renal artery and the concentration of arterially
delivered Ang I in the renal vein; both variables can be
measured.
Regional AT1 and AT2 receptor concentrations
On the basis of Eqs. (7), (9), (10), and (12), the
concentrations of cell surface AT1 receptors in glomerular
and peritubular interstitial fluid can be expressed as a
function of the CIIaC1Glom/CIIaIsfGlom and CIIaC1Pt/CIIaIsfPt
ratios, as follows:
ðCAT1RCsGlomÞ1;2 ¼
ðl=VIsfGlomÞðCIIaC1GlomÞ1;2
ðCIIaIsfGlomÞ1;2
ð44Þ
ðCAT1RCsPtÞ1;2 ¼
ðl=VIsfPtÞðCIIaC1PtÞ1;2
ðCIIaIsfPtÞ1;2
ð45Þ
where
l ¼ ðkdiss þ kintÞktel=ðkasskintÞ ð46Þ
The mechanisms of binding to cell surface AT1 receptors, AT1
receptor-mediated endocytosis, and intracellular degradation
are the same for Ang IIi and Ang IIa, so that
ðCIIiC1PtÞ1;2=ðCIIiIsfPtÞ1;2 ¼ ðCIIaC1PtÞ1;2=ðCIIaIsfPtÞ1;2
ð47Þ
In accordance with Eq. (23), it follows from Eqs. (41) and
(45)–(47) that
ðCAT1RCsPtÞ1;2 ¼
ðg=aÞðl=VIsfPtÞClDiffPt
ðClDiffPt þ bVIsfPtktelÞ ð48Þ
In accordance with Eq. (15), it follows from Eqs. (45) and
(48) that
ðCIIaC1PtÞ1;2 ¼
gðCIIaPvÞ1;2ClDiffPt
ðaClDiffPt þ abVIsfPt ktel þ g ktelÞ ð49Þ
In Eqs. (48) and (49), a is given by Eq. (24), b by Eq. (27),
and g by Eq. (37). In accordance with Eq. (14), it follows
from Eq. (44) that
ðCAT1RCsGlomÞ1;2 ¼
ðl=VIsfGlomÞðCIIaC1GlomÞ1;2Q FF
½ðCIIPaÞ1;2Q FF  ðCIIaC1GlomÞ1;2ktel
ð50Þ
According to Eq. (7), and allowing for our statements on the
distribution of Ang II over the interstitial and tubular fluid
compartments, it can be concluded that
ðCIIaC1GlomÞ1;2 ¼ ðCIIaTÞ1;2  ðCIIaC1PtÞ1;2 ð51Þ
CAT2RCsPt can be expressed as a function of the CIIiCs2Pt/
CIIiIsfPt ratio, as follows
CAT2RCsPt ¼ Kd CIIiCs2Pt=CIIiIsfPt ð52Þ
In accordance with Eq. (23), it follows from Eqs. (43) and
(52) that
CAT2RCsPt ¼ ½Kd=ðaVIsfPtÞðCIIiTÞ2ðCIIiPvÞ2
 ðbþ 1ÞKd ð53Þ
where a is given by Eq. (24), and b by Eq. (27).
By using Eqs. (48)–(53), the local concentrations of AT1
and AT2 receptors can be calculated from measurements of
Ang I and Ang II in blood and in whole tissue. In Figures 4
and 5, the parameters CIIaIsfPt/CIIPa and CAT1RCsPt are
plotted against the CIIaC1Pt/CIIaT ratio. These graphs are
based on Eqs. (15), (45), and (46), and refer to ClDiffPt¼ 0.1,
0.3, and 0.5 ml/min. Experimental data are from van Kats
et al.7 It appears that the CIIaIsfPt/CIIPa ratio decreases as
CAT1RCsPt increases, and that CAT1RCsPt is minimally
10–30Kd at a CIIaC1Pt/CIIaT ratio40.05. Thus, the calculated
concentration of cell surface AT1 receptors in peritubular
interstitial fluid is high, even when only a very small fraction
of cell-associated Ang IIa is localized in this region.
In Figure 6, the parameters CIIaIsfGlom/CIIPa and CAT1
RCsGlom are plotted against the CIIaC1Pt/CIIaT ratio by using
Eqs. (14), (44), and (49)–(51). Comparison with Figure 5
shows that the calculated concentration of cell surface AT1
receptors in the glomerular interstitial fluid decreases from
about 850Kd to 700Kd, as the calculated AT1 receptor
concentration in peritubular tissue increases from zero to
more than 50Kd. The model-based calculations further
demonstrate that the glomerular AT1 receptor concentration
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Figure 4 | Line graphs showing the concentration of arterially
delivered angiotensin II in the peritubular interstitial fluid
compartment (CIIaIsfPt), as a function of the concentration of cell-
associated arterially delivered angiotensin II in peritubular tissue
(CIIaC1Pt). CIIaIsfPt is expressed relative to the plasma concentration of
angiotensin II in the renal artery (CIIPa). CIIaC1Pt is expressed relative to
the total concentration of arterially delivered angiotensin II in the
renal cortex (CIIaT). Graphs refer to peritubular transcapillary diffusive
angiotensin II clearance rates (ClDiffPt) of 0.1, 0.3 and 0.5 ml/min per g
of renal cortex.
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is still above 200Kd, even in the hypothetical case where the
peritubular AT1 receptor concentration is close to infinitely
high.
In Figure 7, the CIIaC1Pt/CIIaT ratio is plotted as a
function of the factor g, as defined by Eq. (37). This factor is a
measure of the AT1 receptor-dependent tissue concentration
of cell-associated paracrine Ang II. The graphs are based on
Eqs. (24), (27), (37), and (49). The values of CIaPv/CIPa in Eq.
(24) and CIiT/(CIiPv VIsfPt) in Eq. (27) are taken to be 0.15
and 180, respectively, as derived from measurements in
control animals.7
DISCUSSION
The model presented in this paper is designed to calculate,
from measurements in blood and in whole tissue, the
concentrations of Ang I and II in various glomerular and
peritubular tissue compartments. The model-based calcula-
tions of the local intrarenal concentrations of Ang II and its
receptors also require quantitative information about a
number of kinetic constants and physical parameters.
Fortunately, such information is at hand for most variables,
but we are not aware of any direct information about the
value of ClDiffPt, the diffusive Ang II clearance rate across the
peritubular capillaries. Our estimate of 0.3 ml/min per g of
renal cortical tissue is based on published measurements of
the distribution half-time of intravenously administered
vasopressin (mol. wt. similar to that of Ang II) in humans,
which is 4–8 min.30 Here t1=2 ¼ 5 min was chosen, corre-
sponding with a whole-body fractional clearance from
plasma of 0.14 min1. Assuming the cardiac output to be
equal to blood volume/min and the regional plasma clearance
during the distribution phase to be proportional to the
regional plasma flow, a fractional clearance of 0.14 min1
corresponds to a peritubular transcapillary clearance rate of
0.3 ml/min per g of renal cortex. In view of the uncertainty
about the exact value of ClDiffPt, the calculations were
extended to values of ClDiffPt ranging from 0.1 to 0.5 ml/min.
Convection may contribute to transport from interstitium
to blood. This tends to decrease the transcapillary concentra-
tions gradients of locally produced Ang I and II and to
increase the gradient of arterially delivered Ang I and II,
resulting in lower calculated levels of CIIiIsfPt and CIIaIsfPt
and therefore higher values of CAT1RCsPt and CAT2RCsPt.
Values of ktel in cardiac and adrenal tissue where similar to
ktel of the renal cortex.
17 As reviewed by Thomas et al.,16
studies of a wide variety of cells, including transfected
Chinese hamster cells, showed a half-time value for AT1
receptor-mediated Ang II endocytosis ranging from 2 to
10 min, corresponding with kint ranging from 0.35 to
0.07 min1. We chose 0.35 min1; lower values will lead to
higher calculated values of l, and therefore to higher
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Figure 5 | Line graphs showing the concentration of cell surface
AT1 receptors in the peritubular interstitial fluid compartment
(CAT1RCsPt), as a function of the concentration of cell-associated
arterially delivered angiotensin II in peritubular tissue (CIIaClPt).
CAT1RCsPt is expressed relative to the equilibrium dissociation
constant (Kd) of the angiotensin II–AT1 receptor reaction. CIIaC1Pt is
expressed relative to the total concentration of arterially delivered
angiotensin II in the renal cortex (CIIaT). Graphs refer to peritubular
transcapillary diffusive angiotensin II clearance rates (ClDiffPt) of 0.1,
0.3, and 0.5 ml/min per g of renal cortex.
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Figure 6 | Line graphs showing the concentration of arterially
delivered angiotensin II in the glomerular interstitial fluid
compartment (CIIaIsfGlom) and the concentration of cell surface
AT1 receptors in glomerular interstitial fluid (CAT1RCsGlom), as a
function of the concentration of cell-associated arterially
delivered angiotensin II in peritubular tissue (CIIaC1Pt). CIIaIsfGlom
is expressed relative to the plasma concentration of angiotensin II in
the renal artery (CIIPa). CAT1RCsGlom is expressed relative to the
equilibrium dissociation constant (Kd) of the angiotensin II–AT1
receptor reaction. CIIaC1Pt is expressed relative to the total
concentration of arterially delivered angiotensin II in the renal cortex
(CIIaT).
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Figure 7 | Line graphs showing the concentration of cell-asso-
ciated arterially delivered angiotensin II in peritubular tissue
(CIIaC1Pt), as a function of the factor c. CIIaC1Pt is expressed relative
to the total concentration of arterially delivered angiotensin II in the
renal cortex (CIIaT). The factor g, as defined by Eq. (37), is a measure of
the AT1 receptor-dependent tissue concentration of cell-associated
paracrine Ang II. Graphs refer to peritubular transcapillary diffusive
angiotensin II clearance rates (ClDiffPt) of 0.1, 0.3, and 0.5 ml/min per g
of renal cortex.
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calculated AT1 receptor concentrations in the Glom and Tb
(see Eqs. (44)–(46)).
Calculations presented in Figures 4–7 made use of data
obtained in animals treated with an ACE inhibitor or AT1
receptor antagonist as well as in control animals. Renal
plasma flow (Q) and filtration fraction (FF) are dealt with in
our model as being constant, whereas in reality ACE
inhibitors and AT1 receptor antagonists can affect these
parameters. The effects on Q and FF that are to be expected,
however, are small as compared with the effects on Ang I and
II levels, so that our approach appears justified.
Our calculations were made on the assumption that
paracrine Ang II (Ang IIi) in the kidney is mainly confined to
the tubular and interstitial tissue compartments. Evidence to
support the presence of renin and Ang II in juxtaglomerular
cells has been reported,31 but it is not known whether this
Ang II is derived from intrarenal production or from blood
plasma.
In this context, it is important to note that the practical
usefulness of our model does not critically depend on a priori
quantitative information about plasma and tissue concentra-
tions of paracrine Ang II. Without such information, the
model can still be used for calculating the local receptor
concentrations and the levels of endocrine and paracrine Ang
II they actually ‘see’, namely when the quantitative distribu-
tion of arterially delivered Ang II (AngIIa) over the
glomerular and peritubular structures is known. Such
information can be provided by more detailed in vivo studies
using systemically or locally (intra-arterially) administered
radiolabeled Ang II, supplemented by in vitro studies of the
kinetics of binding of Ang II to cell surface AT1 and AT2
receptors and its intracellular trafficking. The model predicts
that arterially delivered Ang II mainly binds to cell surface
AT1 receptors in the glomerular tissue region and that the
concentration of these receptors in glomerular interstitial
fluid is more than two orders of magnitude higher than Kd.
This is in accordance with autoradiographic studies demon-
strating that, in rat renal cortex, arterially delivered 125I-Ang
II is mainly confined to the Glom.32 This finding, combined
with the high concentration of glomerular AT1 receptors
predicted by the model, may well explain why glomerular
hemodynamics and, as a consequence, renal sodium hand-
ling, are so responsive to low-dose Ang II infusions. The
model further predicts that AT1 receptors in the peritubular
tissue region are exposed to paracrine rather than endocrine
Ang II, and that the concentration of cell surface AT1
receptors in peritubular interstitial fluid is probably high,
that is 410Kd.
It is often believed that paracrine secretion serves to
establish a high local hormone concentration. However, a
high rate of hormone–receptor complex formation can be
achieved when the concentration of free hormone is low,
provided the local receptor concentration is high. In fact,
binding of paracrine hormone to functional receptors and
subsequent internalization of the receptor–hormone complex
can function as a trapping mechanism to prevent leakage of
hormone into the circulation. Under such conditions, there is
no need for postulating other mechanisms, such as local
extracellular enzymatic degradation, to prevent the escape of
hormone from its local environment.
Experimental data to validate the model are as yet
incomplete, but the model can serve as a framework for
further studies to obtain detailed information on the local
concentrations of AT1 and AT2 receptors and on the
concentrations of endocrine and paracrine Ang II they
actually ‘see’.
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